IA
CORT icon

Icon Advisers’s Corcept Therapeutics CORT Stock Holding History

Icon Advisers’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-46,700
Closed -$565K – 261
2019
Q4 		$565K Sell
46,700
-15,300
-25% -$213K 0.08% 234
2019
Q3 		$877K Hold
62,000
– – 0.13% 207
2019
Q2 		$691K Sell
62,000
-54,700
-47% -$609K 0.07% 231
2019
Q1 		$1.37M Hold
116,700
– – 0.14% 163
2018
Q4 		$1.56M Buy
116,700
+77,000
+194% +$1.02M 0.16% 139
2018
Q3 		$557K Buy
+39,700
New +$555K 0.05% 253
2017
Q1 		– Sell
-27,919
Closed -$203K – 388
2016
Q4 		$203K Sell
27,919
-64,381
-70% -$504K 0.01% 395
2016
Q3 		$600K Buy
+92,300
New +$537K 0.04% 348

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

Icon Advisers's CORT Position: Q1 2020 in Review

Icon Advisers sold out of Corcept Therapeutics (CORT) in Q1 2020, closing a stake of 46,700 shares — an estimated $565K sold.

Icon Advisers first reported a position in CORT in Q3 2016 and held it in 8 quarters. The position peaked at $1.56M in Q4 2018. 204 funds tracked by Wall St. Rank hold CORT as of Q1 2020.

  • Icon Advisers reported no remaining Corcept Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Icon Advisers sold 46,700 Corcept Therapeutics shares in Q1 2020, an estimated $565K.
  • Icon Advisers first reported a position in Corcept Therapeutics in Q3 2016 and held it in 8 quarters.
  • Icon Advisers's Corcept Therapeutics position peaked at $1.56M in Q4 2018.
  • 204 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q1 2020.

Based on Icon Advisers's 13F filing for Q1 2020, filed 1 May 2020.